Apr. 7, 2006 (China Knowledge) – China’s 22 State-owned pharmaceutical companies reported that total income reached RMB 19.71 billion in first two months of this year, an increase of 8.1% over same period last year, according to State-owned Assets Supervision and Administration Commission (SASAC) of the State Council.

Total industrial output amounted to RMB 9.29 billion, increasing by 8.1%.

In January and February, these companies achieved net profit of RMB 700 million, a decline of 12.6% over same period last year. However two companies suffered net loss of RMB 40 million.